| 000 | 01963nam a2200277Ia 4500 | ||
|---|---|---|---|
| 003 | MX-MdCICY | ||
| 005 | 20250625162416.0 | ||
| 040 | _cCICY | ||
| 090 | _aB-18637 | ||
| 245 | 1 | 0 | _aRecent advances in tackling microbial multidrug resistance with essential oils: combinatorial and nano-based strategies. |
| 490 | 0 | _vCritical Reviews in MicroBiology, 46(3), p.338-357., 2020 | |
| 520 | 3 | _aThe emergence of multidrug resistant pathogens is a great challenge to the medical field and a major global health threat requiring novel therapeutic strategies. Among plant products, essential oils have significant antimicrobial properties that make them promising agents in the fight against drug resistant human pathogens. The aim of the present review was to highlight the most important essential oil-based antimicrobial strategies as revealed by recent studies. Synergistic interactions between essential oils or their bioactive compounds in combination with known antibiotics are presented. Also, nanoformulation approaches to boost the antimicrobial activity of essential oils are reviewed in terms of bioefficiency, stability and design of the nanostructured delivery systems. The focus was mainly put on the antimicrobial activity against multi-drug resistant pathogens, also called "ESKAPE" organisms (Enterococcus spp., Staphylococcus aureus, Klebsiella spp., Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp.). | |
| 650 | 1 | 4 | _aESSENTIAL OILS |
| 650 | 1 | 4 | _aMDR-PATHOGENS |
| 650 | 1 | 4 | _aNANOFORMULATION |
| 650 | 1 | 4 | _aSYNERGY |
| 700 | 1 | 2 | _aTrifan, A. |
| 700 | 1 | 2 | _aLuca, S. V. |
| 700 | 1 | 2 | _aGreige-Gerges, H. |
| 700 | 1 | 2 | _aMiron, A. |
| 700 | 1 | 2 | _aGille, E. |
| 700 | 1 | 2 | _aAprotosoaie, A. C. |
| 856 | 4 | 0 |
_uhttps://drive.google.com/file/d/1isS0lDSiJnFmkQg0uWsPX5xXuGZ0CtBu/view?usp=drivesdk _zPara ver el documento ingresa a Google con tu cuenta: @cicy.edu.mx |
| 942 |
_2Loc _cREF1 |
||
| 008 | 250602s9999 xx |||||s2 |||| ||und|d | ||
| 999 |
_c52783 _d52783 |
||